Updated cost-effectiveness analysis of onabotulinumtoxinA for the prevention of headache in adults with chronic migraine who have previously received three or more preventive treatments in the UK

Authors:

Hollier-Hann A, Curry A, Onishchenko K, Akehurst R, Ahmed F, Davies B and Keyzor I

Publication type:

Journal article

Publication name:

Journal of Medical Economics

Citation:

Hollier-Hann A, Curry A, Onishchenko K, Akehurst R, Ahmed F, Davies B and Keyzor I.
Updated cost-effectiveness analysis of onabotulinumtoxinA for the prevention of headache in adults with chronic migraine who have previously received three or more preventive treatments in the UK. J Med Econ. 2019; 1369-6998.

Link to publication ⟶

⟵ Back to Search Results

By continuing to browse or by clicking "Accept All Cookies" you agree to the storing of first and third-party cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
Cookie Policy
Accept All Cookies
By continuing to browse or by clicking "Accept All Cookies" you agree to the storing of first and third-party cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
Cookie Policy
Accept All Cookies